Back to User profile » Dr Hai Liu
Papers published by Dr Hai Liu:
The Combination of Icotinib Hydrochloride and Fluzoparib Enhances the Radiosensitivity of Biliary Tract Cancer Cells
Zhu L, Zhu C, Wang X, Liu H, Zhu Y, Sun X
Cancer Management and Research 2020, 12:11833-11844
Published Date: 19 November 2020
Icotinib hydrochloride enhances chemo- and radiosensitivity by inhibiting EGFR signaling and attenuating RAD51 expression and function in Hela S3 cells
Wang X, Gu Y, Liu H, Shi L, Sun X
OncoTargets and Therapy 2018, 11:1245-1258
Published Date: 5 March 2018
Nimotuzumab abrogates acquired radioresistance of KYSE-150R esophageal cancer cells by inhibiting EGFR signaling and cellular DNA repair
Liu H, Yang W, Gao H, Jiang T, Gu B, Dong Q, Xu W, Wu S, Sun X
OncoTargets and Therapy 2015, 8:509-518
Published Date: 25 February 2015
Doxorubicin-mediated radiosensitivity in multicellular spheroids from a lung cancer cell line is enhanced by composite micelle encapsulation
Xu WH, Han M, Dong Q, Fu ZX, Diao YY, Liu H, Xu J, Jiang HL, Zhang SZ, Zheng S, Gao JQ, Wei QC
International Journal of Nanomedicine 2012, 7:2661-2671
Published Date: 29 May 2012